AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
As a Foreign Invested Enterprise with over 500 members, AstraZeneca is investing into Vietnam 310 million USD from 2020 to 2030 to reduce the burdens of non-communicable diseases, develop local talent, and uplift the domestic biopharmaceutical R&D and manufacturing capabilities.
Over the last three decades accompanying Vietnam’s sustainable development, AstraZeneca has run several impactful programmes in collaboration with the Government, Ministry of Health and healthcare partners to promote disease awareness, prevention and early detection. In recent years, AstraZeneca Vietnam has received the Minister of Health’s Certificate of Merit twice for excellent contributions to advancing cancer treatment (2019) and to Vietnam’s COVID-19 response (2020), amongst various other industry awards.
Floor 8, Horison Tower, 40 Cat Linh, Dong Da district, Ha Noi, Viet Nam